Antibody Drug Conjugates

The 23rd Annual Koch Institute Symposium on Antibody Drug Conjugates: Targeted Cancer Therapies at the Intersection of Chemistry, Biology, and Engineering will take place on Friday, June 27, 2025.

Kicking off with 2022 Nobel Prize winner Carolyn Bertozzi, our powerful speaker lineup features an array of industry and academic leaders who will discuss current advancements and challenges in deploying antibody drug conjugates as anti-cancer agents.

We cordially invite scientists, oncologists, and any other member of the biomedical community to join us in a day of engaging talks, stimulating conversations with colleagues, and of course camaraderie in our collective fight against cancer.

The keynote speaker will be Stanford University's Carolyn Bertozzi. She will be joined by:

• Peter Senter, Fred Hutchinson Cancer Center
• Gerold Meinhardt, Daiichi Sankyo
• Alison Betts, Takeda Pharmaceuticals
• Timothy Lowinger, Mersana Therapeutics
• Laurie Boyer, MIT Koch Institute
• Dane Wittrup, MIT Koch Institute
• Jeremiah Johnson, MIT Koch Institute
• Daša Lipovšek, Aktis Oncology
• Greg Thurber, University of Michigan
• Puja Sapra, AstraZeneca
• Michael Seganish, Merck

See the Koch Institute website for more information on the agenda.

Host or Publisher The Koch Institute at MIT